Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
PURPOSE: The management of epilepsy in children is particularly challenging when seizures are resistant to antiepileptic medications, or undergo many changes in seizure type over time, or have comorbid cognitive, behavioral, or motor deficits. Despite efforts to classify such epilepsies based on clinical and electroencephalographic criteria, many children never receive a definitive etiologic diagnosis. Whole exome sequencing (WES) is proving to be a highly effective method for identifying de novo variants that cause neurologic disorders, especially those associated with abnormal brain development. Herein we explore the utility of WES for identifying candidate causal de novo variants in a cohort of children with heterogeneous sporadic epilepsies without etiologic diagnoses.
METHODS: We performed WES (mean coverage approximately 40×) on 10 trios comprised of unaffected parents and a child with sporadic epilepsy characterized by difficult-to-control seizures and some combination of developmental delay, epileptic encephalopathy, autistic features, cognitive impairment, or motor deficits. Sequence processing and variant calling were performed using standard bioinformatics tools. A custom filtering system was used to prioritize de novo variants of possible functional significance for validation by Sanger sequencing.
KEY FINDINGS: In 9 of 10 probands, we identified one or more de novo variants predicted to alter protein function, for a total of 15. Four probands had de novo mutations in genes previously shown to harbor heterozygous mutations in patients with severe, early onset epilepsies (two in SCN1A, and one each in CDKL5 and EEF1A2). In three children, the de novo variants were in genes with functional roles that are plausibly relevant to epilepsy (KCNH5, CLCN4, and ARHGEF15). The variant in KCNH5 alters one of the highly conserved arginine residues of the voltage sensor of the encoded voltage-gated potassium channel. In vitro analyses using cell-based assays revealed that the CLCN4 mutation greatly impaired ion transport by the ClC-4 2Cl(-) /H(+) -exchanger and that the mutation in ARHGEF15 reduced GEF exchange activity of the gene product, Ephexin5, by about 50%. Of interest, these seven probands all presented with seizures within the first 6 months of life, and six of these have intractable seizures.
SIGNIFICANCE: The finding that 7 of 10 children carried de novo mutations in genes of known or plausible clinical significance to neuronal excitability suggests that WES will be of use for the molecular genetic diagnosis of sporadic epilepsies in children, especially when seizures are of early onset and difficult to control.
Adzhubei,
A method and server for predicting damaging missense mutations.
2010, Pubmed
Adzhubei,
A method and server for predicting damaging missense mutations.
2010,
Pubmed Bamshad,
Exome sequencing as a tool for Mendelian disease gene discovery.
2011,
Pubmed Berg,
Mortality in childhood-onset epilepsy.
2004,
Pubmed Boucard,
High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex.
2012,
Pubmed Bourgeron,
A synaptic trek to autism.
2009,
Pubmed Bras,
Exome sequencing in Parkinson's disease.
2011,
Pubmed Brooks-Kayal,
Epilepsy and autism spectrum disorders: are there common developmental mechanisms?
2010,
Pubmed Brüggemann,
Ether-à-go-go encodes a voltage-gated channel permeable to K+ and Ca2+ and modulated by cAMP.
1993,
Pubmed
,
Xenbase Cartier,
Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
2012,
Pubmed Castrén,
Epilepsy caused by CDKL5 mutations.
2011,
Pubmed Chen,
Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy.
2013,
Pubmed Crimmins,
Transgenic rescue of ataxia mice with neuronal-specific expression of ubiquitin-specific protease 14.
2006,
Pubmed Dan,
Angelman syndrome: current understanding and research prospects.
2009,
Pubmed de Ligt,
Diagnostic exome sequencing in persons with severe intellectual disability.
2012,
Pubmed Depienne,
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients.
2009,
Pubmed DePristo,
A framework for variation discovery and genotyping using next-generation DNA sequencing data.
2011,
Pubmed Epi4K Consortium,
Epi4K: gene discovery in 4,000 genomes.
2012,
Pubmed Friedrich,
Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents.
1999,
Pubmed
,
Xenbase Graves,
Ion channels and epilepsy.
2006,
Pubmed Griffith,
Calcium/calmodulin-dependent protein kinase II and potassium channel subunit eag similarly affect plasticity in Drosophila.
1994,
Pubmed Jentsch,
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.
2008,
Pubmed Kang,
Spatio-temporal transcriptome of the human brain.
2011,
Pubmed Kong,
Rate of de novo mutations and the importance of father's age to disease risk.
2012,
Pubmed Kreienkamp,
The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins.
2000,
Pubmed Kumar,
Evolutionary diagnosis method for variants in personal exomes.
2012,
Pubmed Lemke,
Targeted next generation sequencing as a diagnostic tool in epileptic disorders.
2012,
Pubmed Li,
Fast and accurate long-read alignment with Burrows-Wheeler transform.
2010,
Pubmed Lloyd,
A common molecular basis for three inherited kidney stone diseases.
1996,
Pubmed
,
Xenbase Lui,
The ubiquitin-specific protease USP34 regulates axin stability and Wnt/β-catenin signaling.
2011,
Pubmed Lyon,
Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress.
2012,
Pubmed Margolis,
EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation.
2010,
Pubmed Mulley,
SCN1A mutations and epilepsy.
2005,
Pubmed Neale,
Patterns and rates of exonic de novo mutations in autism spectrum disorders.
2012,
Pubmed Nectoux,
Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome.
2006,
Pubmed Okkenhaug,
The human ClC-4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N-terminus.
2006,
Pubmed O'Roak,
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.
2012,
Pubmed Park,
Two novel HADHB gene mutations in a Korean patient with mitochondrial trifunctional protein deficiency.
2009,
Pubmed Poët,
Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.
2006,
Pubmed Rauch,
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
2012,
Pubmed Rickheit,
Role of ClC-5 in renal endocytosis is unique among ClC exchangers and does not require PY-motif-dependent ubiquitylation.
2010,
Pubmed Saganich,
Cloning of components of a novel subthreshold-activating K(+) channel with a unique pattern of expression in the cerebral cortex.
1999,
Pubmed
,
Xenbase Sahin,
Eph-dependent tyrosine phosphorylation of ephexin1 modulates growth cone collapse.
2005,
Pubmed Sanders,
De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
2012,
Pubmed Scheel,
Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins.
2005,
Pubmed
,
Xenbase Schwarz,
MutationTaster evaluates disease-causing potential of sequence alterations.
2010,
Pubmed Silva,
The latrophilins, "split-personality" receptors.
2010,
Pubmed Stauber,
Sorting motifs of the endosomal/lysosomal CLC chloride transporters.
2010,
Pubmed
,
Xenbase Tuchman,
Epilepsy and autism: neurodevelopmental perspective.
2011,
Pubmed Veeramah,
De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP.
2012,
Pubmed Vissers,
A de novo paradigm for mental retardation.
2010,
Pubmed Wang,
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
2010,
Pubmed Wirrell,
The epileptic encephalopathies of infancy and childhood.
2005,
Pubmed Xiromerisiou,
THAP1 mutations and dystonia phenotypes: genotype phenotype correlations.
2012,
Pubmed Xu,
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia.
2012,
Pubmed Zeng,
Xenopus RCOR2 (REST corepressor 2) interacts with ZMYND8, which is involved in neural differentiation.
2010,
Pubmed
,
Xenbase
